Keros Therapeutics Unveils Exciting Clinical and Preclinical Data at the 64th American Society of Hematology Annual Meeting

Keros Therapeutics Presents Clinical Data from its KER-050 and KER-… Keros Therapeutics Hosts Conference Call and Webcast Keros Therapeutics will be hosting a conference call and webcast today, December 12, 2022, at 4:01 p.m. ET. The event will provide an opportunity for investors, analysts, and the general public to learn more about the latest clinical…

Read More

Starbucks Unveils New Location at Loudoun Station: A Fresh Brew in the Making

A New Starbucks Opens at Loudoun Station: An Exciting Development for Ashburn, Virginia Comstock Holding Companies, Inc. (Comstock), a prominent asset manager, developer, and operator of mixed-use and transit-oriented properties in the Washington, D.C. region, recently announced that a new 1,800-square-foot Starbucks retail location is coming to Ashburn, Virginia. This new Starbucks will be situated…

Read More

RxSight’s Surprising Q1 Revenue Reveal and New Year Resolution for 2025: A Playful Peek!

RxSight’s Q1 2025 Preliminary Revenue Results and Full-Year 2025 Guidance Aliso Viejo, California – RxSight, Inc., a pioneering ophthalmic medical device company, recently unveiled select preliminary revenue figures for the first quarter of 2025. The company, which specializes in delivering personalized vision solutions to patients post-cataract surgery, shared this update with investors on April 2,…

Read More